Alloimmune hepatitis following peripheral stem cell transplantation

Bone Marrow Transplant. 2007 May;39(9):573-5. doi: 10.1038/sj.bmt.1705646. Epub 2007 Mar 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Azathioprine / administration & dosage
  • Busulfan / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Female
  • Graft vs Host Disease / blood
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / prevention & control
  • Hepatitis, Autoimmune / blood
  • Hepatitis, Autoimmune / drug therapy*
  • Hepatitis, Autoimmune / etiology*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Myeloablative Agonists / administration & dosage
  • Peripheral Blood Stem Cell Transplantation* / adverse effects
  • Prednisone / administration & dosage
  • Transplantation Conditioning
  • Transplantation, Homologous

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Myeloablative Agonists
  • Cyclophosphamide
  • Busulfan
  • Azathioprine
  • Prednisone